Related Experiment Video
Updated: Jul 5, 2026
11:34
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells
Galina V Shurin1, Irina L Tourkova, Michael R Shurin
1Department of Pathology, Division of Clinical Immunopathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA. shuringv@upmc.edu
Summary
Chemotherapy drugs can modulate immune cells called dendritic cells (DCs) by affecting small Rho guanosine triphosphatases (GTPases). This suggests new strategies for cancer immunotherapy and chemoimmunotherapy.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Conventional chemotherapy targets rapidly dividing tumor cells.
- Chemotherapy may enhance antitumor immunity by presenting tumor antigens to dendritic cells (DCs).
- Phagocytosis of dying tumor cells by DCs involves small Rho guanosine triphosphatases (GTPases), but their modulation by chemotherapy is unknown.
Purpose of the Study:
- To investigate the effect of various chemotherapeutic agents on small Rho GTPases in DCs.
- To explore the potential of these agents in modulating DC function for immunotherapy.
Main Methods:
- Murine dendritic cells (DCs) were treated with different classes of chemotherapeutic drugs at low, nontoxic concentrations.
- The activity of specific small Rho GTPases (Rac, RhoA, and RhoE) in DCs was analyzed.
Main Results:
- Low-dose chemotherapeutic drugs were found to regulate the activity of Rac, RhoA, and RhoE in DCs.
- Different classes of chemotherapeutic agents exhibited varying effects on Rho GTPase activity.
Conclusions:
- Small Rho GTPases are modulated by various chemotherapeutic drugs in DCs.
- Targeting small Rho GTPases in DCs could offer novel strategies for DC-based vaccines and chemoimmunotherapy.
Related Concept Videos
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:14Rab Proteins
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...